New Treatment Lets 3 Transplant Patients Halt Anti-Rejection Drugs - The New York Times

New Treatment Lets 3 Transplant Patients Halt Anti-Rejection Drugs  The New York TimesFirst-of-its-kind Pitt study allows some liver transplant recipients to stop antirejection drugs  Pittsburgh Post-GazetteCell therapy primed liver transplant patients to avoid organ rejection, small study shows  statnews.comFirst-in-human trial primes immune system to accept donor livers  Medical XpressRegulatory Dendritic Cells Enable Early Drug Withdrawal in Liver Transplants  Bioengineer.org